These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 16045858
1. The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children. Altintas DU, Karakoc GB, Can S, Yilmaz M, Kendirli SG. Allergol Immunopathol (Madr); 2005; 33(4):204-9. PubMed ID: 16045858 [Abstract] [Full Text] [Related]
2. Adrenal function in children with severe asthma treated with high-dose inhaled glucocorticoids: recommended screening tests in outpatient conditions. Breborowicz A, Niedziela M. J Pediatr Endocrinol Metab; 2007 Jul; 20(7):781-9. PubMed ID: 17849740 [Abstract] [Full Text] [Related]
3. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review. Muley P, Shah M, Muley A. Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431 [Abstract] [Full Text] [Related]
4. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. Kannisto S, Korppi M, Remes K, Voutilainen R. J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871 [Abstract] [Full Text] [Related]
5. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Hughes JA, Conry BG, Male SM, Eastell R. Thorax; 1999 Mar; 54(3):223-9. PubMed ID: 10325897 [Abstract] [Full Text] [Related]
6. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma. Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A. Allergol Immunopathol (Madr); 2001 Mar; 29(1):22-7. PubMed ID: 11449531 [Abstract] [Full Text] [Related]
7. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P. J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915 [Abstract] [Full Text] [Related]
8. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study. Harmanci E, Ak I, Ozdemir N, Vardareli E, Elbek O, Uçgun I. Allergol Immunopathol (Madr); 1999 Apr; 27(6):298-303. PubMed ID: 10611554 [Abstract] [Full Text] [Related]
9. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Lipworth BJ, Clark DJ, McFarlane LC. Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826 [Abstract] [Full Text] [Related]
10. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672 [Abstract] [Full Text] [Related]
11. Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide. Acun C, Tomac N, Ermis B, Onk G. Allergy Asthma Proc; 2005 Nov; 26(3):204-6. PubMed ID: 16119035 [Abstract] [Full Text] [Related]
12. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Harrison TW, Wisniewski A, Honour J, Tattersfield AE. Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010 [Abstract] [Full Text] [Related]
13. Osteocalcin, cortisol levels, and bone mineral density in prepubertal children with asthma treated with long-term fluticasone propionate. Ozkaya E, Nursoy MA, Uzuner S, Erenberk U, Çakır E. Horm Res Paediatr; 2012 Mar; 77(6):351-7. PubMed ID: 22760032 [Abstract] [Full Text] [Related]
14. A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma. Ferguson AC, Van Bever HP, Teper AM, Lasytsya O, Goldfrad CH, Whitehead PJ. Respir Med; 2007 Jan; 101(1):118-29. PubMed ID: 16735113 [Abstract] [Full Text] [Related]
15. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation. De Benedictis FM, Del Giudice MM, Vetrella M, Tressanti F, Tronci A, Testi R, Dasic G, Flic12 Study Group. J Asthma; 2005 Jun; 42(5):331-6. PubMed ID: 16116682 [Abstract] [Full Text] [Related]
16. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma. Kuna P, Joubert JR, Greefhorst LA, Magnussen H. Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127 [Abstract] [Full Text] [Related]
17. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Nielsen LP, Dahl R. Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113 [Abstract] [Full Text] [Related]
18. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. Dyer MJ, Halpin DM, Stein K. BMC Fam Pract; 2006 Jun 05; 7():34. PubMed ID: 16753053 [Abstract] [Full Text] [Related]
19. Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test. Pescollderungg L, Radetti G, Gottardi E, Peroni DG, Pietrobelli A, Boner AL. Thorax; 2003 Mar 05; 58(3):227-30. PubMed ID: 12612299 [Abstract] [Full Text] [Related]
20. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze. Cetinkaya F, Kayiran P, Memioglu N, Tarim OF, Eren N, Erdem E. Pediatr Allergy Immunol; 2008 Dec 05; 19(8):773-6. PubMed ID: 18221460 [Abstract] [Full Text] [Related] Page: [Next] [New Search]